Address	2488 Dunwin Drive Mississauga Ontario L5L 1J9 Canada
Employees	-
Website	http://www.trilliumtherapeutics.com
Updated	07/08/2019
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the development of innovative therapies for the treatment of cancer. Its pipeline is comprised of TTI-621, TTI-622, and TTI-2341(EGFR Inhibitor). The company was founded on March 31, 2004 and is headquartered in Toronto, Canada.